Immune therapy with macrophages: Present status and critical requirements for implementation

被引:6
作者
Bartoleyns, J [1 ]
RometLemonne, JL [1 ]
Chokri, M [1 ]
Lopez, M [1 ]
机构
[1] INSERM,PARIS,FRANCE
关键词
D O I
10.1016/S0171-2985(96)80021-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adoptive transfer of activated macrophages has been validated in animal experimental tumor models: clinical trials are ongoing (70 patients up to now). The mechanisms involved are reviewed as well as improved and standardized procedures for macrophage differentiation and activation. New developments including specific Ag presentation and gene therapy are discussed.
引用
收藏
页码:550 / 562
页数:13
相关论文
共 49 条
[41]  
ROSENBERG S, 1990, NEW ENGL J MED, V319, P1676
[42]   PHAGOCYTE RECOGNITION OF CELLS UNDERGOING APOPTOSIS [J].
SAVILL, J ;
FADOK, V ;
HENSON, P ;
HASLETT, C .
IMMUNOLOGY TODAY, 1993, 14 (03) :131-136
[43]  
STERCK R, 1992, RES IMMUNOL, V143, P79
[44]  
STEVENSON HC, 1989, ADOPTIVE CELLULAR IM
[45]  
TAIMI M, 1993, IMMUNOLOGY, V79, P229
[46]   A NONAPEPTIDE ENCODED BY HUMAN GENE MAGE-1 IS RECOGNIZED ON HLA-A1 BY CYTOLYTIC LYMPHOCYTES-T DIRECTED AGAINST TUMOR ANTIGEN-MZ2-E [J].
TRAVERSARI, C ;
VANDERBRUGGEN, P ;
LUESCHER, IF ;
LURQUIN, C ;
CHOMEZ, P ;
VANPEL, A ;
DEPLAEN, E ;
AMARCOSTESEC, A ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1453-1457
[47]  
UNAHUE E, 1984, ANNU REV IMMUNOL, V2, P395
[48]  
YAMAMOTO N, 1995, J IMMUNOL, V154, P2281
[49]  
ZEMBALA M, 1989, HUMAN MONOCYTES, P353